Individuals with transfusion‐dependent beta thalassemia require a high burden of care and
experience significant morbidity from the underlying disease and its treatment, which …

Thalassemia represents a diverse group of inherited hematological disorders characterized
by defective globin chain synthesis, leading to chronic anemia and associated …

We report the national data on the outcomes of hematopoietic stem cell transplantation
(HSCT) for thalassemia major (TM) patients in Turkey on behalf of the Turkish Pediatric Stem …

Background Until now, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the
only effective method to cure Thalassemia major. However, it has not been determined …

We performed a retrospective analysis on 124 patients with transfusion-dependent
thalassemia who were registered in the German pediatric registry for stem cell …

Haploidentical transplantation strategies for patients with transfusion‐dependent
thalassaemia (TD‐TM) remain to be investigated. In this study, 54 paediatric patients with TD …

As an inherited anemia, thalassemia major (TM) is currently only curable with allogeneic
hematopoietic stem cell transplantation (allo-HSCT). Here we report an allo-HSCT protocol …

Thalassemia is the most common autosomal genetic disorder in humans. The pathogenesis
of thalassemia is principally due to the deletion or mutation of globin genes that then leads …

Background Hepatic fibrosis is a common complication in transfusion-dependent
thalassemia patients. Data on the co-transplantation of mesenchymal stem cells (MSCs) with …

Traditionally, bone marrow (BM) has been preferred as a source of stem cells (SCs) in
pediatric hematopoietic SC transplantation (HSCT); however, the use of peripheral blood …